Download Report

Virus and Vaccines – Current Challenges
Which are the major challenges in development of vaccines to fight current epidemics and public health challenges when the vaccines reach the market? The Danish Society of Pharmacology, Toxicology and Medicinal Chemistry invited lecturers from university, industry and health care to provide state of the art information on current challenges in virus and vaccine research. We welcome all to join us for an interesting afternoon at the Benzon Auditorium, Universitetsparken 2, 2100 Copenhagen March 26th 2015, 13.00-‐17.00 -‐ The meeting is free of charge and open to all -‐ Preliminary Program Session 1 Development of vaccines Chairman Claus J. Løland, Head of Pharmacology Section, DSFTM 13.00-‐13.05 DSFTM representative: Introduction to the meeting 13.05-‐13.45 Professor in Experimental Virology Allan Randrup University of Copenhagen DNA vaccines – what will the future bring? 13.45-‐14.25 Paul Chaplin, CEO Bavarian Nordic BN’s technologies and cooperations with private and public partners to develop the Ebola vaccine 14.25-‐15.05 Head of Section Dennis Kristensen Statens Serum Institut Adjuvants: From immunologist’s dirty little secret to vaccinologist’s requisite for success 15.05-‐15.25 Coffee break Session 2 Potential public health challenges of vaccines Chairman Gunnar V. Toft, Section for Toxicology, DSFTM 15.25-‐15.55 Hanne Dorthe Emborg Statens Serum Institut Pandemic and seasonal influenza vaccines – post marketing challenges 15.55-‐16.30 Louise Schouborg Brinth, MD Hvidovre Hospital Autonomic dysfunction as possible side effect to vaccines? 16.30-‐17.00 Niels Gregersen Aarhus University Mitochondrial dysfunction and cellular stress